Skip to main content
Clinical Trials/NCT04880954
NCT04880954
Unknown
Not Applicable

Soft Tissue Mobilization and Rehabilitation on Pain and Physical Functioning for Non-Specific Chronic Knee Pain: A Randomized Clinical Trail

Neuro Performance Integration1 site in 1 country36 target enrollmentMarch 31, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Non-Specific Chronic Knee Pain
Sponsor
Neuro Performance Integration
Enrollment
36
Locations
1
Primary Endpoint
Change in Perceived Pain
Last Updated
4 years ago

Overview

Brief Summary

This is a research study examining if hands-on therapy and prescribed exercise is an effective way to manage and reduce knee pain. It will also look at physical benefits of this treatment including balance, strength, and flexibility.

Participation will include 2 assessment days and a 12-week treatment cycle. Assessments will be conducted during week 1 and after treatment. The treatment will vary based on the assigned group. This may include 12 in-person manual therapy sessions occurring once per week and or 12-weeks of at-home therapy occurring 5 times per week.

The greatest risk of participation includes possible muscle/joint soreness, injury during at-home exercises, and loss of confidentiality.

Registry
clinicaltrials.gov
Start Date
March 31, 2021
End Date
March 31, 2023
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Beverly Albert

Research Director

Neuro Performance Integration

Eligibility Criteria

Inclusion Criteria

  • Adults experiencing non-specific knee pain for 3 or more months. Pain must be 3/10 (VAS) or higher.

Exclusion Criteria

  • Pain due to knee surgery, fracture, tumor, trauma, or those on medication for mood disorder (assessed on case by case basis).

Outcomes

Primary Outcomes

Change in Perceived Pain

Time Frame: This will be measured pre- and post- intervention (week 1 and week 13).

The Visual Analogue Scale (VAS) will be used to quantify pain. The scale ranges from 1 (no pain) to 10 (worst pain).

Secondary Outcomes

  • Modified Clinical Test of Sensory Integration and Balance(This will be measured pre- and post- intervention (week 1 and week 13).)
  • Isometric Strength(This will be measured pre- and post- intervention (week 1 and week 13).)
  • Range of Motion(This will be measured pre- and post- intervention (week 1 and week 13))
  • Limits of Stability(This will be measured pre- and post- intervention (week 1 and week 13).)

Study Sites (1)

Loading locations...

Similar Trials